Three in four AI-listed devices are in the radiology panel; its share peaked in 2020

Share of each year's devices on the FDA's AI-Enabled Medical Device List by the lead panel the list gives each device, by year of final decision, 2016 to June 2026

Show the numbers as a table
Three in four AI-listed devices are in the radiology panel; its share peaked in 2020
PeriodSeriesShare of the year's devicesNote
2016Radiology61.11%11 of 18 devices
2016Cardiovascular22.22%4 of 18 devices
2016Neurology5.56%1 of 18 devices
2016All other panels11.11%2 of 18 devices
2017Radiology59.26%16 of 27 devices
2017Cardiovascular25.93%7 of 27 devices
2017Neurology0.0%0 of 27 devices
2017All other panels14.81%4 of 27 devices
2018Radiology61.54%40 of 65 devices
2018Cardiovascular15.38%10 of 65 devices
2018Neurology9.23%6 of 65 devices
2018All other panels13.85%9 of 65 devices
2019Radiology63.75%51 of 80 devices
2019Cardiovascular18.75%15 of 80 devices
2019Neurology6.25%5 of 80 devices
2019All other panels11.25%9 of 80 devices
2020Radiology86.84%99 of 114 devices
2020Cardiovascular7.02%8 of 114 devices
2020Neurology0.88%1 of 114 devices
2020All other panels5.26%6 of 114 devices
2021Radiology85.27%110 of 129 devices
2021Cardiovascular8.53%11 of 129 devices
2021Neurology2.33%3 of 129 devices
2021All other panels3.88%5 of 129 devices
2022Radiology85.19%138 of 162 devices
2022Cardiovascular8.64%14 of 162 devices
2022Neurology1.23%2 of 162 devices
2022All other panels4.94%8 of 162 devices
2023Radiology78.76%178 of 226 devices
2023Cardiovascular9.29%21 of 226 devices
2023Neurology4.87%11 of 226 devices
2023All other panels7.08%16 of 226 devices
2024Radiology77.87%183 of 235 devices
2024Cardiovascular6.38%15 of 235 devices
2024Neurology6.38%15 of 235 devices
2024All other panels9.36%22 of 235 devices
2025Radiology75.82%254 of 335 devices
2025Cardiovascular8.96%30 of 335 devices
2025Neurology5.67%19 of 335 devices
2025All other panels9.55%32 of 335 devices
Jan to Jun 2026Radiology74.59%135 of 181 devices
Jan to Jun 2026Cardiovascular8.29%15 of 181 devices
Jan to Jun 2026Neurology4.42%8 of 181 devices
Jan to Jun 2026All other panels12.71%23 of 181 devices

About the data

Source
Method
Kent Applied joined each device on the FDA's AI-Enabled Medical Device List (the version current as of September 4, 2026: 1,614 devices with final decisions from September 29, 1995, to June 29, 2026) to its record in the FDA's 510(k), PMA and product classification files by submission number. The FDA says the list is not a comprehensive resource of AI-enabled devices. The panel is the list's "Panel (Lead)" field, the FDA's medical specialty grouping for the type of device, so it describes the device type and not the doctors who use it. All other panels covers 15: Anesthesiology, Gastroenterology-Urology, Hematology, Pathology, Ophthalmic, General and Plastic Surgery, Clinical Chemistry, Orthopedic, Dental, Microbiology, General Hospital, Obstetrics and Gynecology, Clinical Toxicology, Ear Nose & Throat, Immunology. 2026 runs from January to June.
Published
Download the data (CSV)

Free to share and embed with credit to Kent Applied (CC BY 4.0). The source data keeps its own terms.

Related charts

Sources for the figures above: FDA, De Novo Classification Request (opens in a new tab).

Book a 20-minute call

Tyler Kent can measure a question like this one in your own data. Start with a short call.

Prefer to skip the call? Get a written proposal

Or email tyler@kentapplied.com.